356 related articles for article (PubMed ID: 31194992)
1. Asprosin improves the survival of mesenchymal stromal cells in myocardial infarction by inhibiting apoptosis via the activated ERK1/2-SOD2 pathway.
Zhang Z; Tan Y; Zhu L; Zhang B; Feng P; Gao E; Xu C; Wang X; Yi W; Sun Y
Life Sci; 2019 Aug; 231():116554. PubMed ID: 31194992
[TBL] [Abstract][Full Text] [Related]
2. C1q/tumor necrosis factor-related protein-3-engineered mesenchymal stromal cells attenuate cardiac impairment in mice with myocardial infarction.
Zhang Z; Zhu L; Feng P; Tan Y; Zhang B; Gao E; Wang X; Fan C; Wang X; Yi W; Sun Y
Cell Death Dis; 2019 Jul; 10(7):530. PubMed ID: 31296837
[TBL] [Abstract][Full Text] [Related]
3. Sphingosine 1-phosphate promotes mesenchymal stem cell-mediated cardioprotection against myocardial infarction via ERK1/2-MMP-9 and Akt signaling axis.
Chen R; Cai X; Liu J; Bai B; Li X
Life Sci; 2018 Dec; 215():31-42. PubMed ID: 30367841
[TBL] [Abstract][Full Text] [Related]
4. Resistin promotes cardiac homing of mesenchymal stem cells and functional recovery after myocardial ischemia-reperfusion via the ERK1/2-MMP-9 pathway.
He Y; Guo Y; Xia Y; Guo Y; Wang R; Zhang F; Guo L; Liu Y; Yin T; Gao C; Gao E; Li C; Wang S; Zhang L; Yan W; Tao L
Am J Physiol Heart Circ Physiol; 2019 Jan; 316(1):H233-H244. PubMed ID: 30412442
[TBL] [Abstract][Full Text] [Related]
5. C1q/Tumor Necrosis Factor-Related Protein-9 Regulates the Fate of Implanted Mesenchymal Stem Cells and Mobilizes Their Protective Effects Against Ischemic Heart Injury via Multiple Novel Signaling Pathways.
Yan W; Guo Y; Tao L; Lau WB; Gan L; Yan Z; Guo R; Gao E; Wong GW; Koch WL; Wang Y; Ma XL
Circulation; 2017 Nov; 136(22):2162-2177. PubMed ID: 28978553
[TBL] [Abstract][Full Text] [Related]
6. Hydrogen peroxide preconditioning enhances the therapeutic efficacy of Wharton's Jelly mesenchymal stem cells after myocardial infarction.
Zhang J; Chen GH; Wang YW; Zhao J; Duan HF; Liao LM; Zhang XZ; Chen YD; Chen H
Chin Med J (Engl); 2012 Oct; 125(19):3472-8. PubMed ID: 23044308
[TBL] [Abstract][Full Text] [Related]
7. Self-assembling peptide modified with QHREDGS as a novel delivery system for mesenchymal stem cell transplantation after myocardial infarction.
Cai H; Wu FY; Wang QL; Xu P; Mou FF; Shao SJ; Luo ZR; Zhu J; Xuan SS; Lu R; Guo HD
FASEB J; 2019 Jul; 33(7):8306-8320. PubMed ID: 30970221
[TBL] [Abstract][Full Text] [Related]
8. Ultrasound-targeted microbubble destruction promotes PDGF-primed bone mesenchymal stem cell transplantation for myocardial protection in acute Myocardial Infarction in rats.
Sun Z; Cai Y; Chen Y; Jin Q; Zhang Z; Zhang L; Li Y; Huang L; Wang J; Yang Y; Lv Q; Han Z; Xie M; Zhu X
J Nanobiotechnology; 2023 Dec; 21(1):481. PubMed ID: 38102643
[TBL] [Abstract][Full Text] [Related]
9. Guanxin Danshen Formulation improved the effect of mesenchymal stem cells transplantation for the treatment of myocardial infarction probably via enhancing the engraftment.
Han XJ; Li H; Liu CB; Luo ZR; Wang QL; Mou FF; Guo HD
Life Sci; 2019 Sep; 233():116740. PubMed ID: 31398416
[TBL] [Abstract][Full Text] [Related]
10. Genetic modification of mesenchymal stem cells overexpressing CCR1 increases cell viability, migration, engraftment, and capillary density in the injured myocardium.
Huang J; Zhang Z; Guo J; Ni A; Deb A; Zhang L; Mirotsou M; Pratt RE; Dzau VJ
Circ Res; 2010 Jun; 106(11):1753-62. PubMed ID: 20378860
[TBL] [Abstract][Full Text] [Related]
11. Human Umbilical Cord-Derived Mesenchymal Stromal Cells Improve Left Ventricular Function, Perfusion, and Remodeling in a Porcine Model of Chronic Myocardial Ischemia.
Liu CB; Huang H; Sun P; Ma SZ; Liu AH; Xue J; Fu JH; Liang YQ; Liu B; Wu DY; Lü SH; Zhang XZ
Stem Cells Transl Med; 2016 Aug; 5(8):1004-13. PubMed ID: 27334487
[TBL] [Abstract][Full Text] [Related]
12. The effects of mesenchymal stem cells transduced with Akt in a porcine myocardial infarction model.
Lim SY; Kim YS; Ahn Y; Jeong MH; Hong MH; Joo SY; Nam KI; Cho JG; Kang PM; Park JC
Cardiovasc Res; 2006 Jun; 70(3):530-42. PubMed ID: 16563361
[TBL] [Abstract][Full Text] [Related]
13. Rosuvastatin enhances the therapeutic efficacy of adipose-derived mesenchymal stem cells for myocardial infarction via PI3K/Akt and MEK/ERK pathways.
Zhang Z; Li S; Cui M; Gao X; Sun D; Qin X; Narsinh K; Li C; Jia H; Li C; Han Y; Wang H; Cao F
Basic Res Cardiol; 2013 Mar; 108(2):333. PubMed ID: 23386286
[TBL] [Abstract][Full Text] [Related]
14. Transplantation of mesenchymal stem cells preconditioned with hydrogen sulfide enhances repair of myocardial infarction in rats.
Xie X; Sun A; Zhu W; Huang Z; Hu X; Jia J; Zou Y; Ge J
Tohoku J Exp Med; 2012 Jan; 226(1):29-36. PubMed ID: 22186034
[TBL] [Abstract][Full Text] [Related]
15. Reactive oxygen species inhibit adhesion of mesenchymal stem cells implanted into ischemic myocardium via interference of focal adhesion complex.
Song H; Cha MJ; Song BW; Kim IK; Chang W; Lim S; Choi EJ; Ham O; Lee SY; Chung N; Jang Y; Hwang KC
Stem Cells; 2010 Mar; 28(3):555-63. PubMed ID: 20073042
[TBL] [Abstract][Full Text] [Related]
16. Knockdown of insulin-like growth factor 1 exerts a protective effect on hypoxic injury of aged BM-MSCs: role of autophagy.
Yang M; Wen T; Chen H; Deng J; Yang C; Zhang Z
Stem Cell Res Ther; 2018 Oct; 9(1):284. PubMed ID: 30359321
[TBL] [Abstract][Full Text] [Related]
17. MSC Pretreatment for Improved Transplantation Viability Results in Improved Ventricular Function in Infarcted Hearts.
Pittenger MF; Eghtesad S; Sanchez PG; Liu X; Wu Z; Chen L; Griffith BP
Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054878
[TBL] [Abstract][Full Text] [Related]
18. Follistatin-like 1 protects mesenchymal stem cells from hypoxic damage and enhances their therapeutic efficacy in a mouse myocardial infarction model.
Shen H; Cui G; Li Y; Ye W; Sun Y; Zhang Z; Li J; Xu G; Zeng X; Zhang Y; Zhang W; Huang Z; Chen W; Shen Z
Stem Cell Res Ther; 2019 Jan; 10(1):17. PubMed ID: 30635025
[TBL] [Abstract][Full Text] [Related]
19. Metformin induces apoptosis in mesenchymal stromal cells and dampens their therapeutic efficacy in infarcted myocardium.
He X; Yao MW; Zhu M; Liang DL; Guo W; Yang Y; Zhao RS; Ren TT; Ao X; Wang W; Zeng CY; Liang HP; Jiang DP; Yu J; Xu X
Stem Cell Res Ther; 2018 Nov; 9(1):306. PubMed ID: 30409193
[TBL] [Abstract][Full Text] [Related]
20. Tadalafil, a long acting phosphodiesterase inhibitor, promotes bone marrow stem cell survival and their homing into ischemic myocardium for cardiac repair.
Elmadbouh I; Ashraf M
Physiol Rep; 2017 Nov; 5(21):. PubMed ID: 29138357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
